NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1184686909 MD
Verify on CMS → Nuzhat Chalisa, MD
Endocrinology, Diabetes & Metabolism Physician in Channahon, Illinois.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,871 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 146 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
44%
generic claims · 50% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$717.48
18 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Nuzhat Chalisa, MD filed 1,272 Medicare Part D claims in 2023 as a Endocrinology, Diabetes & Metabolism Physician in Channahon, Illinois, prescribing 44% generic.
- 1K
- Part D claims, 2023
- 44%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Nuzhat Chalisa, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
1,272 Top 22% higher than 78% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Nuzhat Chalisa, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Nuzhat Chalisa, MD?
Quality data not reportedPrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
1,272 52% vs specialty avg
Specialty distribution in Illinois
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Illinois providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Nuzhat Chalisa, MD appears in the CMS NPPES registry as an Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 25259 REED STREET, Channahon, IL, 60410, with a listed phone of (815) 467-0555. NPI 1184686909 was issued on 04/05/2006.
Medicare Part D records for calendar year 2023 show 1,272 prescription claims written by this provider, covering 146 Medicare beneficiaries and totaling roughly $532K in drug spend, split 50% brand-name and 44% generic by claim count.
Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,871 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1184686909 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 04/05/2006 |
Hospital and facility affiliations
Facilities where Nuzhat Chalisa, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Morris Hospital
Channahon, IL
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Nuzhat Chalisa, MD. Source: openpaymentsdata.cms.gov.
Total received
$717
Largest payer
SANOFI-AVENTIS U.S. LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Illinois IDFPR 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~42K Illinois medical licensees in 2023 - they are NOT specific to Nuzhat Chalisa, MD. To verify Nuzhat Chalisa, MD's current license status, search the IDFPR public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
106
Total board actions, Illinois 2023
Across 103 cases
2.52
Actions per 1,000 licensees
Illinois statewide rate
probation
Most common action type
38 cases
IDFPR publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Illinois disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Nuzhat Chalisa, MD - brand share 50.0%
Endocrinology, Diabetes & Metabolism Physician average
50% brand-name claims vs 44% generic, on 1,272 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,272
Total Claims
$532K
Total Drug Cost
146
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,170
- Total Day Supply
- 63,859
- Brand vs Generic
- 50% brand / 44% generic
- Brand Drug Cost
- $514K
- Generic Drug Cost
- $8K
Patient Demographics
- Average Patient Age
- 66.6 years
- Avg HCC Risk Score
- 1.50
- Gender Split
- 71% female / 29% male
- Age Distribution
- <65: 39, 65-74: 73, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Nuzhat Chalisa, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
303 claims
- Ozempic 106
Ozempic
106 claims
- Metformin Hcl 95
Metformin Hcl
95 claims
- Hydrocortisone 57
Hydrocortisone
57 claims
- Farxiga 55
Farxiga
55 claims
- Synthroid 44
Synthroid
44 claims
- Jardiance 40
Jardiance
40 claims
- Methimazole 30
Methimazole
30 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 303 |
| Ozempic Semaglutide | 106 |
| Metformin Hcl | 95 |
| Hydrocortisone | 57 |
| Farxiga Dapagliflozin Propanediol | 55 |
| Synthroid Levothyroxine Sodium | 44 |
| Jardiance Empagliflozin | 40 |
| Methimazole | 30 |
| Mounjaro Tirzepatide | 29 |
| Trulicity Dulaglutide | 28 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in IL →
All providers in Illinois →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Nuzhat Chalisa, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
7,871
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider
Nuzhat Chalisa, MD's 1,272 claims are below the specialty average of 2,639.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Illinois
Other clinicians with the same primary specialty enrolled in Illinois, drawn from the same CMS NPPES roster as Chalisa.
Dr. Maha Abboud
MD FACE
Melrose Park, IL
Dr. Jumana Abdelkarim
MD
Springfield, IL
Dr. Toufic Abdo
MD
Champaign, IL
Dr. Issa Abedmahmoud
MD
Herrin, IL
Dr. Makarem Abulimon
M.D.
Springfield, IL
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Illinois medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Endocrinology, Diabetes & Metabolism Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Illinois
Frequently Asked Questions
What is Nuzhat Chalisa, MD's specialty? ▼
Nuzhat Chalisa, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Channahon, Illinois. Credentials: MD.
How much does Nuzhat Chalisa, MD prescribe under Medicare Part D? ▼
In 2023, Nuzhat Chalisa, MD wrote 1,272 Medicare Part D claims totaling $532K in drug costs for 146 beneficiaries.
Where is Nuzhat Chalisa, MD located? ▼
Nuzhat Chalisa, MD is located at 25259 REED STREET, Channahon, IL, 60410. Phone: (815) 467-0555.
What is Nuzhat Chalisa, MD's NPI number? ▼
Nuzhat Chalisa, MD's National Provider Identifier (NPI) is 1184686909, issued on 04/05/2006.
Does Nuzhat Chalisa, MD prescribe more brand-name or generic drugs? ▼
Nuzhat Chalisa, MD's prescribing is 50% brand-name and 44% generic drugs by claim count, with $514K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 7,871 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Nuzhat Chalisa, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Nuzhat Chalisa, MD's most frequently prescribed drugs include Levothyroxine Sodium, Ozempic, Metformin Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Nuzhat Chalisa, MD accept Medicare? ▼
Nuzhat Chalisa, MD appears in CMS Medicare data with 1,272 Part D claims and 146 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Nuzhat Chalisa, MD's credentials? ▼
Nuzhat Chalisa, MD's NPI is 1184686909 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.